Literature DB >> 33420599

Magnetic anchoring and guidance-assisted endoscopic irreversible electroporation for gastric mucosal ablation: a preclinical study in canine model.

Qingshan Li1, Xuyao Gao2, Yuchi Zhang1, Xuan Han1, Zhuoqun Li1, Yu Zhang1, Yue Wang1, Lihong Liang1, Dake Chu3, Zheng Wu1, Bo Wang1, Rongqian Wu1, Yi Lv1, Fenggang Ren4.   

Abstract

BACKGROUND: The aim of this study was to evaluate the feasibility, safety, and efficacy of magnetic anchoring and guidance-assisted endoscopic irreversible electroporation (MAG-IRE) for gastric mucosal ablation.
METHODS: A catheter-based, donut-like, and MAG-assisted electrode was developed. MAG-IRE for gastric mucosal ablation was performed in eight beagle canines. The parameters of one set of IRE was 500 V voltage, 100 μs pulse duration, and 99 pulses. The MAG time, operation time, success rate, and adverse events were measured. Endoscopic examination was performed from 30 min to 28 days post-IRE. Full-thickness gastric tissue was harvested by wedge biopsy for histopathological analysis.
RESULTS: 30 (93.75%) of the 32 lesions were successfully ablated by MAG-IRE. The median MAG time was 300 s (IQR 120-422.5 s), and the median operation time was 491.5 s (IQR 358.3-632.5 s). No adverse events occurred. Ulceration was observed, starting from 3 days post-IRE. The mucosa healed 14 to 28 days post-IRE. Hematoxylin-Eosin (H&E) staining showed inflammatory infiltration, edema, and congestion in the ablated mucosa. Masson's Trichrome staining showed that the gastric wall and blood vessels in the ablation area were intact. TUNEL assay showed diffuse positive cells in ablated mucosa as early as 30 min post-IRE.
CONCLUSIONS: MAG-IRE for gastric mucosal ablation is feasible, safe, and effective. It can be a potential therapeutic option for minimally invasive treatment of gastric neoplasm.

Entities:  

Keywords:  Endoscopic treatment; Gastric cancer; Irreversible electroporation; Magnetic anchoring and guidance; Tumor ablation

Year:  2021        PMID: 33420599     DOI: 10.1007/s00464-020-08245-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

2.  Irreversible electroporation: a new ablation modality--clinical implications.

Authors:  Boris Rubinsky; Gary Onik; Paul Mikus
Journal:  Technol Cancer Res Treat       Date:  2007-02

3.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E C Smyth; M Verheij; W Allum; D Cunningham; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

4.  Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Thomas Wimmer; Sebastien Monette; Simon Y Kimm; Majid Maybody; Stephen B Solomon; Jonathan A Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

6.  Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study.

Authors:  Marine Camus; Bertrand Napoléon; Ariane Vienne; Marc Le Rhun; Sarah Leblanc; Maximilien Barret; Stanislas Chaussade; Françoise Robin; Nadira Kaddour; Frederic Prat
Journal:  Gastrointest Endosc       Date:  2018-04-13       Impact factor: 9.427

Review 7.  Gastric adenocarcinoma.

Authors:  Jaffer A Ajani; Jeeyun Lee; Takeshi Sano; Yelena Y Janjigian; Daiming Fan; Shumei Song
Journal:  Nat Rev Dis Primers       Date:  2017-06-01       Impact factor: 52.329

8.  Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer.

Authors:  Hiroyuki Ono; Kenshi Yao; Mitsuhiro Fujishiro; Ichiro Oda; Satoshi Nimura; Naohisa Yahagi; Hiroyasu Iishi; Masashi Oka; Yoichi Ajioka; Masao Ichinose; Toshiyuki Matsui
Journal:  Dig Endosc       Date:  2015-10-04       Impact factor: 7.559

9.  High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy.

Authors:  Bart Geboers; Hester J Scheffer; Philip M Graybill; Alette H Ruarus; Sanne Nieuwenhuizen; Robbert S Puijk; Petrousjka M van den Tol; Rafael V Davalos; Boris Rubinsky; Tanja D de Gruijl; Damijan Miklavčič; Martijn R Meijerink
Journal:  Radiology       Date:  2020-03-24       Impact factor: 11.105

10.  Single-session endoscopic resection and focal radiofrequency ablation for short-segment Barrett's esophagus with early neoplasia.

Authors:  Maximilien Barret; Kamar Belghazi; Bas L A M Weusten; Jacques J G H M Bergman; Roos E Pouw
Journal:  Gastrointest Endosc       Date:  2016-01-06       Impact factor: 9.427

View more
  2 in total

1.  Survival model database of human digestive system cells exposed to electroporation pulses: An in vitro and in silico study.

Authors:  Xuan Han; Nana Zhang; Yuchi Zhang; Zhuoqun Li; Yingxue Wang; Lujing Mao; Tianshuai He; Qingshan Li; Jiawen Zhao; Xue Chen; Yixuan Li; Zitong Qin; Yi Lv; Fenggang Ren
Journal:  Front Public Health       Date:  2022-09-05

Review 2.  Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.

Authors:  Nana Zhang; Zhuoqun Li; Xuan Han; Ziyu Zhu; Zhujun Li; Yan Zhao; Zhijun Liu; Yi Lv
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.